FAKTOR OPTIONSSCHEIN - JOHNSON & JOHNSON Share Price

Certificat

DE000UM15883

Market Closed - Börse Stuttgart 01:18:40 01/06/2024 am IST
9.62 EUR -4.75% Intraday chart for FAKTOR OPTIONSSCHEIN - JOHNSON & JOHNSON
Current month-16.35%
1 month-16.35%
Date Price Change
31/24/31 9.62 -4.75%
30/24/30 10.1 -3.72%
29/24/29 10.49 +0.96%
28/24/28 10.39 +16.35%
27/24/27 8.93 -6.59%

Delayed Quote Börse Stuttgart

Last update May 01, 2024 at 01:18 am IST

More quotes

Static data

Product typeProductos Exóticos
Buy / SellCALL
Underlying JOHNSON & JOHNSON
Issuer UBS
WKN UM1588
ISINDE000UM15883
Date issued 20/02/2024
Strike 174.3 $
Maturity Unlimited
Parity 2.61 : 1
Emission price 8.03
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 12.01
Lowest since issue 6.09
Spread 0.3
Spread %3.01%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
146.7 USD
Average target price
171.9 USD
Spread / Average Target
+17.23%
Consensus